(Q52586565)

English

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden.

scientific article published on 16 April 2018

Statements

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit